טוען...
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
AIMS: To determine the effects of empagliflozin on adiposity indices among patients with type 2 diabetes mellitus. METHODS: Changes in weight, waist circumference, estimated total body fat, index of central obesity and visceral adiposity index were assessed using analysis of covariance and testing o...
שמור ב:
| הוצא לאור ב: | Diab Vasc Dis Res |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4768401/ https://ncbi.nlm.nih.gov/pubmed/26873905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164115616901 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|